Real-time enrollment status for this invasive pulmonary aspergillosis clinical trial
Current Status
Terminated
Checked: March 2, 2026 at 10:17 AM UTC
| NCT Number | NCT05238116 |
| Recruiting Status | Terminated |
| Condition | Invasive Pulmonary Aspergillosis |
| Phase | Clinical Trial |
| Target Enrollment | 123 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Pulmocide Ltd |
| Last Updated on CT.gov | January 15, 2026 (Jan 15, 2026) |
As of March 2, 2026: Clinical trial NCT05238116 is currently terminated participants. This clinical trial study for invasive pulmonary aspergillosis is not currently accepting new participants at 20 locations across the United States. The study is sponsored by Pulmocide Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05238116 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05238116 was last updated Jan 15, 2026 (January 15, 2026). HelloStudys verifies this status automatically.